Altimmune Appoints M. Scott Harris, M.D. as Chief Medical Officer

    NEXT STORY
    Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT™) in Immuno-oncology
    PREV STORY
    Fennec Appoints Shubh Goel as Chief Commercial Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30, 2017

    BEIJING, Sept. 15, 2017 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the ...

    author_avatar
    NASDAQ Market News

    Syndax Expands Pipeline With Exclusive Worldwide License Agreement for UCB’s Colony Stimulating Factor 1 Receptor (CSF-1R) Antibody Program

    WALTHAM, Mass., July 06, 2016 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical ...

    author_avatar
    NASDAQ Market News

    TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l’essai de phase III ADMIRE-CD du Cx601

    COMMUNIQUÉ DE PRESSE TiGenix annonce la publication dans Gastroenterology des résultats de la semaine ...

    PM360 Staff
    PM360 Staff